August 6th, 2020
•Inhibitors of histone acetyltransferases (HATs, also known as lysine acetyltransferases), such as CBP/p300, are potential therapeutics for treating cancer. However, rigorous methods for validating these inhibitors are needed. Three in vitro methods for validation include HAT assays with recombinant acetyltransferases, immunoblotting for histone acetylation in cell culture, and ChIP-qPCR.
Videos relacionados
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados